粪便血红蛋白浓度可预测全因死亡率
研究基于丹麦结直肠癌筛查队列,纳入444,910名受邀筛查者,平均随访56.5个月,比较不同粪便免疫化学检测(FIT)浓度组的结直肠癌特异死亡与全因死亡风险。结果显示,FIT浓度升高与结直肠癌死亡及全因死亡风险增加相关,即使在欧洲筛查项目判为阴性的浓度范围亦如此。
要点
- 在FIT浓度<4 μg hb/g粪便的个体中,结直肠癌死亡风险随FIT浓度升高而增加,风险比范围为2.6至25.9。
- 全因死亡风险同样随FIT浓度升高而增加,风险比范围为1.6至5.3(参照组FIT<4 μg hb/g粪便)。
- FIT浓度低至4-9 μg hb/g粪便时,结直肠癌特异死亡与全因死亡风险均已升高。
核心结论
- 结直肠癌死亡风险随FIT浓度升高而增加,即使FIT浓度在所有欧洲筛查项目中均被视为阴性时亦然。
- 可检测到粪便血液的个体全因死亡风险亦增加,且FIT浓度低至4-9 μg hb/g粪便时风险已升高。
研究设计与样本
- 研究为队列研究,利用丹麦国家死因登记对筛查参与者进行随访。
- 数据来自丹麦结直肠癌筛查数据库并补充FIT浓度,共纳入444,910名受邀参加筛查的丹麦人。
- 采用多变量Cox比例风险回归模型比较不同FIT浓度组的结直肠癌特异死亡与全因死亡。
主要发现
- 平均随访56.5个月期间,25,234名(5.7%)受邀者死亡,其中结直肠癌导致1,120例死亡。
- 结直肠癌死亡风险随FIT浓度升高而增加,与FIT浓度<4 μg hb/g粪便的个体相比,风险比范围为2.6至25.9。
- 非结直肠癌原因导致24,114例死亡,全因死亡风险随FIT浓度升高而增加,与FIT浓度<4 μg hb/g粪便的个体相比,风险比范围为1.6至5.3。
关键数值与推荐
- 结直肠癌死亡风险比范围2.6至25.9,参照组为FIT浓度<4 μg hb/g粪便的个体。
- 全因死亡风险比范围1.6至5.3,参照组为FIT浓度<4 μg hb/g粪便的个体。
- FIT浓度低至4-9 μg hb/g粪便时,结直肠癌特异死亡与全因死亡风险均已升高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Population-based screening for colorectal cancer by a faecal immunochemical test (FIT) is recommended by the European Union. Detectable faecal haemoglobin can indicate colorectal neoplasia as well as other conditions. A positive FIT predicts an increased risk of death from colorectal cancer but might also predict an increased risk of all-cause mortality. METHODS: A cohort of screening participants was followed using the Danish National Register of Causes of Death. Data were retrieved from the Danish Colorectal Cancer Screening Database supplemented with FIT concentrations. Colorectal cancer specific and all-cause mortality were compared between FIT concentration groups using multivariate cox proportional hazards regression models. FINDINGS: In 444,910 Danes invited for the screening program, 25,234 (5·7%) died during a mean follow-up of 56·5 months. Colorectal cancer caused 1120 deaths. The risk of colorectal cancer death increased with the increasing FIT concentration. The hazard ratios ranged from 2·6 to 25·9 compared to individuals with FIT concentrations <4 μg hb/g faeces. Causes other than colorectal cancer caused 24,114 deaths. The risk of all-cause death increased with the increasing FIT concentration, with the hazard ratios ranging from 1·6 to 5·3 compared to individuals with FIT concentrations <4 μg hb/g faeces. INTERPRETATION: The risk of colorectal cancer mortality increased with the increasing FIT concentrations even for FIT concentrations considered negative in all European screening programs. The risk of all-cause mortality was also increased for individuals with detectable faecal blood. For colorectal cancer specific mortality and all-cause mortality, the risk was increased at the FIT concentrations as low as 4-9 μg hb/g faeces. FUNDING: The study was funded by the Odense University Hospital grants A3610 and A2359.
引用
- Deding U, Kaalby L, Steele R, et al. Faecal haemoglobin concentration predicts all-cause mortality. Eur J Cancer. 2023. PMID: 36889038. doi:10.1016/j.ejca.2023.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。